HRT Financial’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-68,191
| Closed | -$1.15M | – | 3008 |
|
|
2024
Q4 | $1.15M | Buy |
+68,191
| New | +$1.15M | 0.01% | 872 |
|
|
2024
Q3 | – | Sell |
-27,687
| Closed | -$227K | – | 2810 |
|
|
2024
Q2 | $227K | Buy |
+27,687
| New | +$227K | ﹤0.01% | 1446 |
|
|
2023
Q3 | – | Sell |
-1,485
| Closed | -$19K | – | 2723 |
|
|
2023
Q2 | $19K | Sell |
1,485
-558
| -27% | -$7.14K | ﹤0.01% | 1907 |
|
|
2023
Q1 | $26K | Sell |
2,043
-16,093
| -89% | -$205K | ﹤0.01% | 1983 |
|
|
2022
Q4 | $272K | Sell |
18,136
-90,228
| -83% | -$1.35M | ﹤0.01% | 1620 |
|
|
2022
Q3 | $1.28M | Buy |
+108,364
| New | +$1.28M | 0.01% | 752 |
|
|
2022
Q2 | – | Sell |
-13,867
| Closed | -$414K | – | 3411 |
|
|
2022
Q1 | $414K | Sell |
13,867
-1,071
| -7% | -$32K | ﹤0.01% | 1791 |
|
|
2021
Q4 | $395K | Sell |
14,938
-3,144
| -17% | -$83.1K | ﹤0.01% | 1856 |
|
|
2021
Q3 | $656K | Buy |
18,082
+16,771
| +1,279% | +$608K | ﹤0.01% | 1579 |
|
|
2021
Q2 | $56K | Sell |
1,311
-1,459
| -53% | -$62.3K | ﹤0.01% | 2571 |
|
|
2021
Q1 | $94K | Sell |
2,770
-2,879
| -51% | -$97.7K | ﹤0.01% | 2239 |
|
|
2020
Q4 | $197K | Buy |
+5,649
| New | +$197K | ﹤0.01% | 1427 |
|
|
2020
Q1 | – | Sell |
-1,104
| Closed | -$23K | – | 1148 |
|
|
2019
Q4 | $23K | Buy |
+1,104
| New | +$23K | ﹤0.01% | 1039 |
|
|
2019
Q1 | – | Sell |
-1,221
| Closed | -$28K | – | 709 |
|
|
2018
Q4 | $28K | Buy |
+1,221
| New | +$28K | ﹤0.01% | 529 |
|